Turku

Finland

291 total trials 110 recruiting

Filter these 291 trials by phase, condition, sponsor and more.

Open in Search →

Pembrolizumab (MK-3475) and pembrolizumab in combination with other investigational agents in high risk NMIBC patients unresponsive to BCG Ended

2022-502526-41-00 4 2016-03-15 Non-Muscle Invasive Bladder Cancer (NMIBC)
Mavacamten Impact on Myocardial Structure in Obstructive Hypertrophic Cardiomyopathy Ended

2022-502316-36-00 11 Symptomatic Obstructive Hypertrophic Cardiomyopathy
A study to investigate the efficacy and safety of luveltamab tazevibulin versus IC chemotherapy in women with ovarian cancer (including fall … Ended

2024-512477-27-00 4 Advanced Epithelial Ovarian Cancer (including Fallopian Tube or Primar

Showing 289–291 of 291 trials